Gary Skala’s claim that 14 years of Risperdal caused his diabetes went to trial in New Jersey yesterday in the first personal injury lawsuit against Johnson & Johnson to be presented to a jury. The trial follows J&J’s losses in Risperdal-related cases in Louisiana, South Carolina, and to the United States Government, and starts two weeks after J&J’s settlement of claims regarding fraudulent marketing of Risperdal in Texas.
Read more Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.